Skip to main content
Caplight Logo









MultivisionDx

MultivisionDx

Private
HelsinkiHealthcare & Life Scienceshttps://multivision.ai/

Last Round

Pre Seed

Dec 3, 2025

Total Funding Raised

$1.87M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

MultivisionDx is a biotechnology company that develops AI-powered decision-support tools for personalized diagnosis and treatment selection for solid cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting, Data as a Service

AI Layer

Application

Keywords

spatial biologydigital pathologycancer diagnosticsprecision medicinein vitro diagnosticsIVDclinical decision supportbiomarker discoveryspatial transcriptomicscomputer visiononcology AImultiplexed imagingresearch use onlyRUOAI pathology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MultivisionDx Comparables

Compare MultivisionDx with similar companies based on industry and business-model similarity.

MultivisionDx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nucleai
76%
DoMore Diagnostics
76%
Aignostics
70%

MultivisionDx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedDec 3, 2025
GrantNov 1, 2022

Key People

Founding team and executive leadership

Karolina Punovuori

Co-Founder & Chief Scientific Officer

Founding Team

Michael Wittinger

Chief Executive Officer

Executive Team

MultivisionDx Investors

Notable investors and investment history

MultivisionDx investors
InvestorRounds
Helsinki University FundsPre Seed
Business FinlandGrant
AntlerPre Seed
Kaikarhenni OyPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 3, 2025

    $1.18M raised in Pre Seed round.

  • Nov 1, 2022

    $690K grant received from Business Finland

MultivisionDx Filings

Explore SEC and related filing metadata, where available.

MultivisionDx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about MultivisionDx's valuation, stock price, and market status.

Is MultivisionDx a public or private company?

MultivisionDx is a private company.

What is the current stock price of MultivisionDx?

MultivisionDx is a private company with no public stock price. No recent secondary market data is available.

How much is MultivisionDx worth (valuation)?

Valuation information for MultivisionDx is not publicly available.

Can I buy MultivisionDx stock?

MultivisionDx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was MultivisionDx's last funding round?

MultivisionDx's most recent funding round was Pre Seed on December 3, 2025.

Who are the main investors in MultivisionDx?

Key investors in MultivisionDx include Antler AI Disrupt.

Will MultivisionDx IPO soon?

No public IPO plans have been announced for MultivisionDx.

How can I track MultivisionDx secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MultivisionDx's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHelsinki
Employee Range4
Year Founded2025
Last FundingDec 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?